Intravitreal bevacizumab treatment of macular edema in central retinal vein occlusion: One-year results

International Ophthalmology

Volumn 30, Issue 1, 2010, Pages 15-22

  Beutel, Julia ^a   Ziemssen, Focke ^b   Lüke, Matthias ^a   Partsch, Michael ^b   Bartz Schmidt, Karl Ulrich ^b   Gelisken, Faik ^b  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Anti VEGF; Bevacizumab; Central retinal vein occlusion; Macular edema; Treatment

Indexed keywords

BEVACIZUMAB;

ADULT; AGED; ARTICLE; CENTRAL RETINA VEIN OCCLUSION; CLINICAL ARTICLE; EYE EXAMINATION; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; MALE; RETINA MACULA EDEMA; RETROSPECTIVE STUDY; VISUAL ACUITY;

AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; INJECTIONS, INTRAOCULAR; MACULAR EDEMA; MALE; MIDDLE AGED; RETINA; RETINAL VEIN OCCLUSION; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 76449106209     PISSN: 01655701     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10792-008-9282-7     Document Type: Article

References (11)

1. The Central Vein Occlusion Study Group M Report 1995 Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion Ophthalmology 102 1425 1433
2. Q Mohamed RL McIntosh SM Saw, et al. 2007 Interventions for central retinal vein occlusion: an evidence-based systematic review Ophthalmology 114 507 519 10.1016/j.ophtha.2006.11.011 10.1016/j.ophtha.2006.11.011 17324695 524 (Pubitemid 46282974)
3. RA Costa R Jorge D Calucci, et al. 2007 Intravitreal bevacizumab (avastin) for central and hemicentral retinal vein occlusions: IBeVO study Retina 27 141 149 10.1097/IAE.0b013e31802eff83 10.1097/IAE.0b013e31802eff83 17290194 (Pubitemid 46245639)
4. J Hsu RS Kaiser A Sivalingam, et al. 2007 Intravitreal bevacizumab (avastin) in central retinal vein occlusion Retina 27 1013 1019 10.1097/IAE.0b013e318050ca7c 18040237 (Pubitemid 350304000)
5. D Iturralde RF Spaide CB Meyerle, et al. 2006 Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study Retina 26 279 284 10.1097/00006982-200603000-00005 10.1097/00006982-200603000-00005 16508427 (Pubitemid 44318180)
6. SA Pai R Shetty PB Vijayan, et al. 2007 Clinical, anatomic, and electrophysiologic evaluation following intravitreal bevacizumab for macular edema in retinal vein occlusion Am J Ophthalmol 143 601 606 10.1016/j.ajo.2006. 12.037 10.1016/j.ajo.2006.12.037 1:CAS:528:DC%2BD2sXjsVWitbw%3D 17306753 (Pubitemid 46452523)
7. SG Priglinger AH Wolf TC Kreutzer, et al. 2007 Intravitreal bevacizumab injections for treatment of central retinal vein occlusion: six-month results of a prospective trial Retina 27 1004 1012 10.1097/IAE.0b013e3180ed458d 18040236 (Pubitemid 350303999)
8. KB Schaal AE Höh A Scheuerle, et al. 2007 Bevacizumab zur Therapie des Makulaödems infolge venöser retinaler Gefäverschlüsse Ophthalmologe 104 285 289 10.1007/s00347-007-1509-x 10.1007/s00347-007-1509-x 1:CAS:528:DC%2BD2sXktlOhtrk%3D 17372737
9. UH Spandau AK Ihloff JB Jonas 2006 Intravitreal bevacizumab treatment of macular oedema due to central retinal vein occlusion Acta Ophthalmol Scand 84 555 556 10.1111/j.1600-0420.2006.00740.x 10.1111/j.1600-0420.2006.00740.x 16879582 (Pubitemid 44109048)
10. A Stahl H Agostini LL Hansen, et al. 2007 Bevacizumab in retinal vein occlusion-results of a prospective case series Graefes Arch Clin Exp Ophthalmol 245 1429 1436 10.1007/s00417-007-0569-6 10.1007/s00417-007-0569-6 1:CAS:528:DC%2BD2sXhtVajs73L 17356824 (Pubitemid 47423323)
11. Y Matsumoto KB Freund E Peiretti, et al. 2007 Rebound macular edema following bevacizumab (Avastin) therapy for retinal venous occlusive disease Retina 27 426 431 10.1097/IAE.0b013e31804a7af2 10.1097/IAE.0b013e31804a7af2 17420693 (Pubitemid 46624281)